952 related articles for article (PubMed ID: 19385940)
1. Advanced proteomic technologies for cancer biomarker discovery.
Wong SC; Chan CM; Ma BB; Lam MY; Choi GC; Au TC; Chan AS; Chan AT
Expert Rev Proteomics; 2009 Apr; 6(2):123-34. PubMed ID: 19385940
[TBL] [Abstract][Full Text] [Related]
2. Oncoproteomics of hepatocellular carcinoma: from cancer markers' discovery to functional pathways.
Sun S; Lee NP; Poon RT; Fan ST; He QY; Lau GK; Luk JM
Liver Int; 2007 Oct; 27(8):1021-38. PubMed ID: 17845530
[TBL] [Abstract][Full Text] [Related]
3. A data-analytic strategy for protein biomarker discovery: profiling of high-dimensional proteomic data for cancer detection.
Yasui Y; Pepe M; Thompson ML; Adam BL; Wright GL; Qu Y; Potter JD; Winget M; Thornquist M; Feng Z
Biostatistics; 2003 Jul; 4(3):449-63. PubMed ID: 12925511
[TBL] [Abstract][Full Text] [Related]
4. Protein profiling for cancer biomarker discovery using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and infrared imaging: a review.
Bakry R; Rainer M; Huck CW; Bonn GK
Anal Chim Acta; 2011 Mar; 690(1):26-34. PubMed ID: 21414433
[TBL] [Abstract][Full Text] [Related]
5. Proteomic patterns: their potential for disease diagnosis.
Xiao Z; Prieto D; Conrads TP; Veenstra TD; Issaq HJ
Mol Cell Endocrinol; 2005 Jan; 230(1-2):95-106. PubMed ID: 15664456
[TBL] [Abstract][Full Text] [Related]
6. Global and targeted quantitative proteomics for biomarker discovery.
Veenstra TD
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):3-11. PubMed ID: 17023222
[TBL] [Abstract][Full Text] [Related]
7. The molecular make-up of a tumour: proteomics in cancer research.
Kolch W; Mischak H; Pitt AR
Clin Sci (Lond); 2005 May; 108(5):369-83. PubMed ID: 15831087
[TBL] [Abstract][Full Text] [Related]
8. An introduction into proteomics and its clinical applications.
Ahram M
Saudi Med J; 2007 Apr; 28(4):499-507. PubMed ID: 17457467
[TBL] [Abstract][Full Text] [Related]
9. Biomarker discovery for kidney diseases by mass spectrometry.
Niwa T
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(2):148-53. PubMed ID: 18024247
[TBL] [Abstract][Full Text] [Related]
10. [Proteomic profiling: the potential of Seldi-Tof for the identification of new cancer biomarkers].
Solassol J; Marin P; Maudelonde T; Mangé A
Bull Cancer; 2005 Sep; 92(9):763-8. PubMed ID: 16203265
[TBL] [Abstract][Full Text] [Related]
11. Clinical proteomics and mass spectrometry profiling for cancer detection.
Solassol J; Jacot W; Lhermitte L; Boulle N; Maudelonde T; Mangé A
Expert Rev Proteomics; 2006 Jun; 3(3):311-20. PubMed ID: 16771703
[TBL] [Abstract][Full Text] [Related]
12. Proteomics for the identification of new prostate cancer biomarkers.
Ornstein DK; Tyson DR
Urol Oncol; 2006; 24(3):231-6. PubMed ID: 16678055
[TBL] [Abstract][Full Text] [Related]
13. Proteomic methods for biomarker discovery in urine.
Wilkey DW; Merchant ML
Semin Nephrol; 2007 Nov; 27(6):584-96. PubMed ID: 18061841
[TBL] [Abstract][Full Text] [Related]
14. Clinical proteomics in breast cancer: a review.
Gast MC; Schellens JH; Beijnen JH
Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
[TBL] [Abstract][Full Text] [Related]
15. Present status of clinical proteomic analysis for the early detection and determination of therapeutic strategy in lung cancer.
Hirano T; Kato H
Ann Thorac Cardiovasc Surg; 2006 Feb; 12(1):4-9. PubMed ID: 16572067
[TBL] [Abstract][Full Text] [Related]
16. Application of proteomic technologies to discover and identify biomarkers for excessive alcohol consumption: a review.
Nomura F; Tomonaga T; Sogawa K; Wu D; Ohashi T
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Aug; 855(1):35-41. PubMed ID: 17561455
[TBL] [Abstract][Full Text] [Related]
17. Clinical perspectives of high-resolution mass spectrometry-based proteomics in neuroscience: exemplified in amyotrophic lateral sclerosis biomarker discovery research.
Ekegren T; Hanrieder J; Bergquist J
J Mass Spectrom; 2008 May; 43(5):559-71. PubMed ID: 18416436
[TBL] [Abstract][Full Text] [Related]
18. What does it need to be a biomarker? Relationships between resolution, differential quantification and statistical validation of protein surrogate biomarkers.
Schrattenholz A; Groebe K
Electrophoresis; 2007 Jun; 28(12):1970-9. PubMed ID: 17516580
[TBL] [Abstract][Full Text] [Related]
19. Methods of comparative proteomic profiling for disease diagnostics.
Steel LF; Haab BB; Hanash SM
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 815(1-2):275-84. PubMed ID: 15652816
[TBL] [Abstract][Full Text] [Related]
20. Comparative profiling of serum glycoproteome by sequential purification of glycoproteins and 2-nitrobenzensulfenyl (NBS) stable isotope labeling: a new approach for the novel biomarker discovery for cancer.
Ueda K; Katagiri T; Shimada T; Irie S; Sato TA; Nakamura Y; Daigo Y
J Proteome Res; 2007 Sep; 6(9):3475-83. PubMed ID: 17705522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]